Raptiva, a drug used for treating psoriasis, was pulled from the market on April 9, 2009.
The FDA has reported that Raptiva can cause the development of a condition called progressive multifocal leukoencephalopathy. This is a neurologic disease that can be fatal. Anyone currently using Raptiva should communicate with their physicians so they can begin tapering off the drug, as it will no longer be available after June 8, 2009. Physicians are not supposed to issue any new prescriptions.
Read More Details on Raptiva and progressive multifocal leukoencephalopathy
